title: The impact of gender and anchor drugs on TDF renal toxicity.
authors.forename: Eugenia
authors.initials: E
authors.lastname: Quiros-Roldan
authors.forename: Silvia
authors.initials: S
authors.lastname: Amadasi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Paraninfo
authors.forename: Ilaria
authors.initials: I
authors.lastname: Izzo
authors.forename: Roberto
authors.initials: R
authors.lastname: Allegri
authors.forename: Davide
authors.initials: D
authors.lastname: Motta
authors.forename: Francesca
authors.initials: F
authors.lastname: Gatti
authors.forename: Graziella
authors.initials: G
authors.lastname: Cristini
authors.forename: Giampiero
authors.initials: G
authors.lastname: Carosi
authors.forename: Monia
authors.initials: M
authors.lastname: Mendeni
authors.forename: Carlo
authors.initials: C
authors.lastname: Torti
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D000068679:Emtricitabine; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012737:Sex Factors; D000068698:Tenofovir; D000099227:Abacavir
chemical_list: D000225:Adenine; D019380:Anti-HIV Agents; D003841:Deoxycytidine; D015224:Dideoxynucleosides; D000068679:Emtricitabine; D019259:Lamivudine; D063065:Organophosphonates; D000068698:Tenofovir; D000099227:Abacavir